Farhad Kamali

7.2k total citations · 2 hit papers
99 papers, 4.8k citations indexed

About

Farhad Kamali is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Farhad Kamali has authored 99 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pharmacology, 31 papers in Cardiology and Cardiovascular Medicine and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Farhad Kamali's work include Pharmacogenetics and Drug Metabolism (40 papers), Atrial Fibrillation Management and Outcomes (25 papers) and Hormonal Regulation and Hypertension (17 papers). Farhad Kamali is often cited by papers focused on Pharmacogenetics and Drug Metabolism (40 papers), Atrial Fibrillation Management and Outcomes (25 papers) and Hormonal Regulation and Hypertension (17 papers). Farhad Kamali collaborates with scholars based in United Kingdom, Sweden and Netherlands. Farhad Kamali's co-authors include Hilary Wynne, Dorothy Newbury‐Birch, Peter Avery, Ann K. Daly, C. H. Ashton, Tayyaba Khan, Patrick Kesteven, Elizabeth Sconce, Peter J. Kelly and Peter Wood and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Blood.

In The Last Decade

Farhad Kamali

97 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

2005 686 citations Elizabeth Sconce, Tayyaba Khan et al. profile →
A Randomized Trial of Genotype-Guided Dosing of Warfarin

2013 590 citations Munir Pirmohamed, Andrea Jorgensen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Farhad Kamali United Kingdom	34	2.1k	939	779	705	537	99	4.8k
M. D. Rawlins United Kingdom	45	1.3k 0.6×	790 0.8×	297 0.4×	693 1.0×	1.6k 2.9×	221	8.6k
James M Wright Canada	47	651 0.3×	2.1k 2.2×	896 1.2×	250 0.4×	423 0.8×	166	5.9k
J. Feely Ireland	51	830 0.4×	2.5k 2.7×	1.1k 1.5×	375 0.5×	660 1.2×	255	7.8k
D. Craig Brater United States	50	1.2k 0.6×	2.5k 2.7×	631 0.8×	369 0.5×	2.0k 3.7×	197	8.4k
Peter A. G. M. De Smet Netherlands	37	948 0.5×	346 0.4×	327 0.4×	352 0.5×	400 0.7×	166	4.7k
Alison Ward United Kingdom	32	1.0k 0.5×	821 0.9×	242 0.3×	402 0.6×	151 0.3×	98	4.2k
Johan Ahlner Sweden	41	549 0.3×	560 0.6×	324 0.4×	195 0.3×	881 1.6×	171	4.9k
Bernard Bégaud France	34	344 0.2×	902 1.0×	465 0.6×	278 0.4×	1.1k 2.1×	179	6.8k
Hillel Halkin Israel	39	581 0.3×	1.4k 1.5×	1.5k 2.0×	103 0.1×	474 0.9×	128	5.4k
Simon Maxwell United Kingdom	44	317 0.2×	974 1.0×	419 0.5×	544 0.8×	298 0.6×	156	7.0k

Countries citing papers authored by Farhad Kamali

Since Specialization

Citations

This map shows the geographic impact of Farhad Kamali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhad Kamali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhad Kamali more than expected).

Fields of papers citing papers by Farhad Kamali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farhad Kamali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhad Kamali. The network helps show where Farhad Kamali may publish in the future.

Co-authorship network of co-authors of Farhad Kamali

This figure shows the co-authorship network connecting the top 25 collaborators of Farhad Kamali. A scholar is included among the top collaborators of Farhad Kamali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farhad Kamali. Farhad Kamali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Avery, Peter, et al.. (2020). Elderly people are inherently sensitive to the pharmacological activity of rivaroxaban: implications for DOAC prescribing. Journal of Thrombosis and Thrombolysis. 52(1). 170–178. 7 indexed citations

Wynne, Hilary, et al.. (2018). Effect of genetic and patient factors on warfarin pharmacodynamics following warfarin withdrawal: Implications for patients undergoing surgery. Thrombosis Research. 171. 167–170. 4 indexed citations

Kamali, Farhad, et al.. (2016). Effect of Statins on Functional Expression of Membrane Transporters in L6 Rat Skeletal Muscle Cells. 1(1). 17–26. 1 indexed citations

Wynne, Hilary, et al.. (2016). Impact of age on long‐term anticoagulation and how gender and monitoring setting affect it: implications for decision making and patient management. British Journal of Clinical Pharmacology. 82(4). 1076–1083. 9 indexed citations

Pirmohamed, Munir, Farhad Kamali, Ann K. Daly, & Mia Wadelius. (2015). Oral anticoagulation: a critique of recent advances and controversies. Trends in Pharmacological Sciences. 36(3). 153–163. 58 indexed citations

Kamali, Farhad, et al.. (2014). Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England. Age and Ageing. 43(5). 708–711. 7 indexed citations

Lane, Steven, Andrea Jorgensen, Panos Deloukas, et al.. (2011). The population pharmacokinetics of R‐ and S‐warfarin: effect of genetic and clinical factors. British Journal of Clinical Pharmacology. 73(1). 66–76. 60 indexed citations

Jorgensen, Andrea, Andrew Keniry, Anita Hanson, et al.. (2009). Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective study. Pharmacogenetics and Genomics. 19(10). 800–812. 55 indexed citations

Sconce, Elizabeth & Farhad Kamali. (2006). Appraisal of current vitamin K dosing algorithms for the reversal of over‐anticoagulation with warfarin: the need for a more tailored dosing regimen. European Journal Of Haematology. 77(6). 457–462. 34 indexed citations

10.

Kamali, Farhad & Munir Pirmohamed. (2006). The future prospects of pharmacogenetics in oral anticoagulation therapy. British Journal of Clinical Pharmacology. 61(6). 746–751. 41 indexed citations

11.

Sconce, Elizabeth, et al.. (2005). Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation. Thrombosis and Haemostasis. 93(5). 872–875. 73 indexed citations

12.

Khan, Tayyaba, Hilary Wynne, Peter Wood, et al.. (2004). Dietary vitamin K influences intra‐individual variability in anticoagulant response to warfarin. British Journal of Haematology. 124(3). 348–354. 80 indexed citations

13.

Kamali, Farhad, et al.. (2001). Temporal variations in plasma vitamin K and lipid concentrations and clotting factor activity in humans. American Journal of Hematology. 68(3). 159–163. 13 indexed citations

14.

Newbury‐Birch, Dorothy, David Walshaw, & Farhad Kamali. (2001). Drink and drugs: from medical students to doctors. Drug and Alcohol Dependence. 64(3). 265–270. 147 indexed citations

15.

Newbury‐Birch, Dorothy, Martin White, & Farhad Kamali. (2000). Factors influencing alcohol and illicit drug use amongst medical students. Drug and Alcohol Dependence. 59(2). 125–130. 158 indexed citations

16.

Kamali, Farhad, et al.. (1998). Analgesic effects of lamotrigine and phenytoin on cold-induced pain: a crossover placebo-controlled study in healthy volunteers. Pain. 76(3). 357–363. 44 indexed citations

17.

Kamali, Farhad, Angela Howes, S. H. L. Thomas, Gary A. Ford, & Eric Snoeck. (1997). A pharmacokinetic and pharmacodynamic interaction study between nebivolol and the H₂‐receptor antagonists cimetidine and ranitidine. British Journal of Clinical Pharmacology. 43(2). 201–204. 29 indexed citations

18.

Ball, David, et al.. (1995). The pharmacokinetics of phenytoin in gingival crevicular fluid and plasma in relation to gingival overgrowth. Journal Of Clinical Periodontology. 22(12). 942–945. 12 indexed citations

19.

Kamali, Farhad, et al.. (1995). Lack of interaction between zidovudine and 4-methyl-amino-antipyrine, the active metabolite of metamizole, in human liver in vitro.. PubMed. 17(5). 299–301. 2 indexed citations

20.

Kamali, Farhad & Simon H. L. Thomas. (1994). Effect of saliva flow rate on saliva phenytoin concentrations: implications for therapeutic monitoring. European Journal of Clinical Pharmacology. 46(6). 565–7. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact